title: Response to Ivarie: Competitive bioreactor hens on the horizon.
authors.affiliation: Origen Therapeutics, 1450 Rollins Road, Burlingame, CA 94010, USA. retches@origentherapeutics.com
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Etches
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics* / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000096:biosynthesis* / Q000235:genetics; D019149:Bioreactors; D002645:Chickens / Q000235:genetics* / Q000378:metabolism; D004527:Egg Proteins / Q000096:biosynthesis* / Q000235:genetics; D005818:Genetic Engineering / Q000379:methods / Q000639:trends; D006801:Humans; D009928:Organ Specificity / Q000235:genetics; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D004527:Egg Proteins; D011994:Recombinant Proteins